The safety and effectiveness of open-label extended-release carbamazepine in the treatment of children and adolescents with bipolar I disorder suffering from a manic or mixed episode.

Neuropsychiatr Dis Treat · 2014 · PMC4156006 · PMID 25210452

Europe PMC DOI

hedged sentence

0.0001

closest p · 0.0× alpha

0.0001

boldest claim

The sentences

highly significantP <0.0001actually significant

YMRS ERC treatment was associated with highly significant reductions ( P <0.0001) in the YMRS at all study visits when visit-wise data from the children and adolescents were analyzed together.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.